Nektar Therapeutics
N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the .kappa. opioid receptor
Last updated:
Abstract:
Compounds and pharmaceutically acceptable salts and solvates thereof are described. The compounds relate to and/or have application(s) in (among others) the fields of drug discovery, pharmacotherapy, physiology and organic chemistry.
Status:
Grant
Type:
Utility
Filling date:
14 May 2019
Issue date:
8 Feb 2022